MENU

Fox Chase Cancer Center News

“Radiologists should not dismiss low density lesions of the kidney on non-contrast scans, especially if the lesion is not homogenous,” Uzzo said.
December 13, 2019

Low Density Renal Masses Should Not Be Dismissed as Benign

PHILADELPHIA (December 13, 2019) – Robert Uzzo and colleagues found that type-2 papillary renal cell carcinomas were more likely to have lower pre-contrast attenuation than type-1 tumors.

Neil Johnson and colleagues have been working to gain a better understanding of why resistance occurs.
December 11, 2019

BRCA1 Gene Rearrangements May Help Identify PARP Inhibitor Resistance

PHILADELPHIA (December 11, 2019) – New research indicates that BRCA1 gene rearrangements are responsible for generating partially active proteins that drive the development of resistance to PARP inhibitors.

The work of Sergei Grivennikov, PhD, is included in this year’s rankings by the Web of Science Group.
December 6, 2019

Fox Chase Faculty Member Recognized as Highly Cited Researcher for His Work on Immune Responses and Cancer

PHILADELPHIA (December 6, 2019) – The work of Sergei Grivennikov, PhD, is included in this year’s rankings by the Web of Science Group.

December 5, 2019

Fox Chase Cancer Center Launches New Employee Cancer Screening Initiative

To make cancer screening more convenient for staff, Fox Chase Cancer Center kicked off its Employee Cancer Screening Initiative this October.

The goal of this project is to evaluate and exploit the mechanisms of inducing programmed cell death using polyunsaturated fatty acids in triple-negative breast cancer (TNBC).
December 3, 2019

Peterson Receives Grant for Innovative Approach to Attacking Metastatic Triple-Negative Breast Cancer

PHILADELPHIA (December 3, 2019) – Fox Chase Cancer Center researcher Jeffrey Peterson, PhD, has been awarded a $1.4 million grant by the U.S. Department of Defense to evaluate and exploit the mechanisms of inducing programmed cell death using polyunsaturated fatty acids in TNBC.

December 2, 2019

Fox Chase Cancer Center Offers Tips to Reduce Your Risk for Cancer

PHILADELPHIA (December 2, 2019) – Did you know that your chances of developing cancer may be affected by your lifestyle?  According to the American Cancer Society (ACS), an estimated 42 percent of cancer cases and 45 percent of cancer deaths in the U.S. are attributed to modifiable risk factors.

November 27, 2019

Epigenetic Therapies Could Modulate EGFR Amplification, Effecting Therapeutic Response

PHILADELPHIA (November 27, 2019) – Prolonged treatment with EGFR inhibitors can reduce the copies of EGFR, leading to therapy resistance, according to Johnathan R. Whetstine, PhD. Whetstine, the study’s corresponding author.

The 2019 Fellows induction ceremony will take place on Saturday, February 15, 2020, in Seattle during the American Association for the AAAS 2020 Annual Meeting.
November 26, 2019

Erica Golemis of Fox Chase Cancer Center Named 2019 AAAS Fellow

PHILADELPHIA (November 26, 2019) – Erica Golemis, PhD, professor, deputy chief science officer, leader of the Molecular Therapeutics Program, and The William Wikoff Smith Chair in Cancer Research at Fox Chase Cancer Center, has been named a 2019 Fellow of the American Association for the Advancement of Science.

Pages

Connect with Fox Chase